{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-019472","form_type":"8-K/A","ticker":"VTRS","cik":"0001792044","company_name":"Viatris Inc","filed_at":"2024-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.548944+00:00","generated_at":"2026-06-06T15:07:57.988168+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"medium","headline":"Viatris signs definitive agreement to sell OTC business to Cooper Consumer Health","bullets":["Viatris exercised put option on Jan 26, 2024; signed Transaction Agreement on Jan 29, 2024.","Sale includes substantially all OTC products business; consideration includes estimated cash and contingent additional amount (undisclosed).","Closing conditions include European Commission, French Ministry approvals; Italian and Serbian consents already obtained."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-019472","json":"https://secwatch.observer/filing/0001193125-24-019472.json","markdown":"https://secwatch.observer/filing/0001193125-24-019472.md","text":"https://secwatch.observer/filing/0001193125-24-019472.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1792044/000119312524019472/0001193125-24-019472-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1792044/000119312524019472/d619190d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:07:57.988168+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a278aa4da710646ad83bbaf52c4bed377b5a8100","claim":"Viatris Inc entered into Transaction Agreement with Cooper Consumer Health SAS valued at purchase of substantially all of Viatris’ over-the-counter products business (effective 2024-01-29).","evidence_excerpt":"on January 29, 2024, Viatris, Viatris Italia S.r.l., a wholly-owned subsidiary of Viatris, Ipex AB, a wholly-owned subsidiary of Viatris, and the Buyer Parties entered into the Transaction Agreement.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1792044/000119312524019472/0001193125-24-019472-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Cooper Consumer Health SAS"},{"label":"Value","value":"purchase of substantially all of Viatris’ over-the-counter products business"},{"label":"Effective","value":"2024-01-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}